Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
NCT00989612
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza investigational vaccine GSK2340274A
Sponsor
GlaxoSmithKline